This is the authors' abstract. We don't add key points for this paper.
Research led by Katrin Andreasson suggests that fixing age-induced metabolic defects in myeloid cells would suffice to reverse cognitive impairment and to restore synaptic plasticity to the level of young subjects, at least in mice. This opens up the possibility to develop rejuvenating strategies by targeting immune dysfunction.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Knobloch et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: